Brain metabolic correlates of apathy in amyotrophic lateral sclerosis: An 18F-FDG-positron emission tomography stud.


Journal

European journal of neurology
ISSN: 1468-1331
Titre abrégé: Eur J Neurol
Pays: England
ID NLM: 9506311

Informations de publication

Date de publication:
03 2021
Historique:
received: 31 08 2020
revised: 23 10 2020
accepted: 05 11 2020
pubmed: 12 11 2020
medline: 13 8 2021
entrez: 11 11 2020
Statut: ppublish

Résumé

The aim of this study was to evaluate brain metabolic correlates of apathy in amyotrophic lateral sclerosis (ALS). A total of 165 ALS patients underwent In the whole sample, the "after" apathy subscore negatively correlated with metabolism in the dorsolateral prefrontal cortex (DLPFC), dorsomedial prefrontal cortex (DMPFC), ventrolateral prefrontal cortex (VLPFC), premotor cortex (PMC) and anterior cingulate cortex (ACC), and insula bilaterally. A positive correlation was found in the cerebellum and pons. The "before-after" gap negatively correlated with metabolism in bilateral DLPFC, DMPFC and PMC, and left VLPFC and ACC, and positively correlated with cerebellar and pontine clusters. Among patients with an "after" apathy subscore ≥65, we found no difference between those with "before" apathy subscores ≥65 and <65. Patients with a "before-after" gap ≥22, compared to patients with a gap <22, showed relative hypometabolism in bilateral DLPFC and DMPFC, and left ACC and PMC, and relative cerebellar and pontine hypermetabolism. No studies on brain

Sections du résumé

BACKGROUND AND PURPOSE
The aim of this study was to evaluate brain metabolic correlates of apathy in amyotrophic lateral sclerosis (ALS).
METHODS
A total of 165 ALS patients underwent
RESULTS
In the whole sample, the "after" apathy subscore negatively correlated with metabolism in the dorsolateral prefrontal cortex (DLPFC), dorsomedial prefrontal cortex (DMPFC), ventrolateral prefrontal cortex (VLPFC), premotor cortex (PMC) and anterior cingulate cortex (ACC), and insula bilaterally. A positive correlation was found in the cerebellum and pons. The "before-after" gap negatively correlated with metabolism in bilateral DLPFC, DMPFC and PMC, and left VLPFC and ACC, and positively correlated with cerebellar and pontine clusters. Among patients with an "after" apathy subscore ≥65, we found no difference between those with "before" apathy subscores ≥65 and <65. Patients with a "before-after" gap ≥22, compared to patients with a gap <22, showed relative hypometabolism in bilateral DLPFC and DMPFC, and left ACC and PMC, and relative cerebellar and pontine hypermetabolism.
CONCLUSION
No studies on brain

Identifiants

pubmed: 33175462
doi: 10.1111/ene.14637
doi:

Substances chimiques

Fluorodeoxyglucose F18 0Z5B2CJX4D

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

745-753

Informations de copyright

© 2020 European Academy of Neurology.

Références

van Es MA, Hardiman O, Chio A, et al. Amyotrophic lateral sclerosis. Lancet. 2017;390(10107):2084-2098. https://doi.org/10.1016/S0140-6736(17)31287-4
Phukan J, Elamin M, Bede P, et al. The syndrome of cognitive impairment in amyotrophic lateral sclerosis: a population-based study. J Neurol Neurosurg Psychiatry. 2012;83(1):102-108. https://doi.org/10.1136/jnnp-2011-300188
Montuschi A, Iazzolino B, Calvo A, et al. Cognitive correlates in amyotrophic lateral sclerosis: a population-based study in Italy. J Neurol Neurosurg Psychiatry. 2015;86(2):168-173. https://doi.org/10.1136/jnnp-2013-307223
Strong MJ, Grace GM, Freedman M, et al. Consensus criteria for the diagnosis of frontotemporal cognitive and behavioural syndromes in amyotrophic lateral sclerosis. Amyotroph Lateral Scler. 2009;10(3):131-146. https://doi.org/10.1080/17482960802654364
Strong MJ, Abrahams S, Goldstein LH, et al. Amyotrophic lateral sclerosis - frontotemporal spectrum disorder (ALS-FTSD): Revised diagnostic criteria. Amyotroph Lateral Scler Frontotemporal Degener. 2017;18(3-4):153-174. https://doi.org/10.1080/21678421.2016.1267768
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (DSM-5). United States: American Psychiatric Publishing; 2013.
Robert P, Lanctôt KL, Agüera-Ortiz L, et al. Is it time to revise the diagnostic criteria for apathy in brain disorders? The 2018 international consensus group. Eur Psychiatry. 2018;54:71-76. https://doi.org/10.1016/j.eurpsy.2018.07.008
Grace J, Malloy P. Frontal Systems Behavior Scale (FrSBe): Professional Manual. United States: Psychological Assessment Resources; 2001.
Jack CR, Vemuri P, Wiste HJ, et al. Shapes of the trajectories of 5 major biomarkers of Alzheimer disease. Arch Neurol. 2012;69(7):856-867. https://doi.org/10.1001/archneurol.2011.3405
Brooks BR, Miller RG, Swash M, Munsat TL. World federation of neurology research group on motor neuron diseases. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord. 2000;1(5):293-299.
Pagani M, Chiò A, Valentini MC, et al. Functional pattern of brain FDG-PET in amyotrophic lateral sclerosis. Neurology. 2014;83(12):1067-1074. https://doi.org/10.1212/WNL.0000000000000792
Chiò A, Mora G, Moglia C, et al. Secular trends of amyotrophic lateral sclerosis: the piemonte and valle d'aosta register. JAMA Neurol. 2017;74(9):1097. https://doi.org/10.1001/jamaneurol.2017.1387
Della Rosa PA, Cerami C, Gallivanone F, et al. A standardized [18F]-FDG-PET template for spatial normalization in statistical parametric mapping of dementia. Neuroinformatics. 2014;12(4):575-593. https://doi.org/10.1007/s12021-014-9235-4
Stevens JP. Applied Multivariate Statistics for the Social Sciences. United States: Lawrence Erlbaum Associates; 1996.
Zamboni G, Huey ED, Krueger F, Nichelli PF, Grafman J. Apathy and disinhibition in frontotemporal dementia: insights into their neural correlates. Neurology. 2008;71(10):736-742. https://doi.org/10.1212/01.wnl.0000324920.96835.95
Massimo L, Powers JP, Evans LK, et al. Apathy in frontotemporal degeneration: neuroanatomical evidence of impaired goal-directed behavior. Front Hum Neurosci. 2015;9:611. https://doi.org/10.3389/fnhum.2015.00611
Consonni M, Cappa SF, Dalla Bella E, Contarino VE, Lauria G. Cortical correlates of behavioural change in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry. 2019;90(4):380-386. https://doi.org/10.1136/jnnp-2018-318619
Franceschi M, Anchisi D, Pelati O, et al. Glucose metabolism and serotonin receptors in the frontotemporal lobe degeneration. Ann Neurol. 2005;57(2):216-225. https://doi.org/10.1002/ana.20365
Peters F, Perani D, Herholz K, et al. Orbitofrontal dysfunction related to both apathy and disinhibition in frontotemporal dementia. Dement Geriatr Cogn Disord. 2006;21(5-6):373-379. https://doi.org/10.1159/000091898
Fernández-Matarrubia M, Matías-Guiu JA, Cabrera-Martín MN, et al. Different apathy clinical profile and neural correlates in behavioral variant frontotemporal dementia and Alzheimer's disease. Int J Geriatr Psychiatry. 2018;33(1):141-150. https://doi.org/10.1002/gps.4695
Ducharme S, Price BH, Dickerson BC. Apathy: a neurocircuitry model based on frontotemporal dementia. J Neurol Neurosurg Psychiatry. 2018;89(4):389-396. https://doi.org/10.1136/jnnp-2017-316277
Canosa A, Pagani M, Cistaro A, et al. 18F-FDG-PET correlates of cognitive impairment in ALS. Neurology. 2016;86(1):44-49. https://doi.org/10.1212/WNL.0000000000002242
Schmahmann JD, Sherman JC. The cerebellar cognitive affective syndrome. Brain. 1998;121(Pt 4):561-579. https://doi.org/10.1093/brain/121.4.561
Guo CC, Tan R, Hodges JR, Hu X, Sami S, Hornberger M. Network-selective vulnerability of the human cerebellum to Alzheimer's disease and frontotemporal dementia. Brain. 2016;139(Pt 5):1527-1538. https://doi.org/10.1093/brain/aww003
Mitoma H, Buffo A, Gelfo F, et al. Consensus paper. cerebellar reserve: from cerebellar physiology to cerebellar disorders. Cerebellum (London, England). 2020;19(1):131-153. https://doi.org/10.1007/s12311-019-01091-9
Ibáñez V, Pietrini P, Alexander GE, et al. Regional glucose metabolic abnormalities are not the result of atrophy in Alzheimer's disease. Neurology. 1998;50(6):1585-1593. https://doi.org/10.1212/wnl.50.6.1585

Auteurs

Antonio Canosa (A)

ALS Centre, "Rita Levi Montalcini" Department of Neuroscience, University of Turin, Turin, Italy.
Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino, Turin, Italy.

Veria Vacchiano (V)

Bellaria Hospital, IRCCS Istituto delle Scienze Neurologiche di Bologna, Bologna, Italy.
Department of Biomedical and NeuroMotor Sciences (DIBINEM), University of Bologna, Bologna, Italy.

Fabrizio D'Ovidio (F)

ALS Centre, "Rita Levi Montalcini" Department of Neuroscience, University of Turin, Turin, Italy.

Andrea Calvo (A)

ALS Centre, "Rita Levi Montalcini" Department of Neuroscience, University of Turin, Turin, Italy.
Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino, Turin, Italy.
Neuroscience Institute of Turin (NIT), Turin, Italy.

Cristina Moglia (C)

ALS Centre, "Rita Levi Montalcini" Department of Neuroscience, University of Turin, Turin, Italy.
Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino, Turin, Italy.

Umberto Manera (U)

ALS Centre, "Rita Levi Montalcini" Department of Neuroscience, University of Turin, Turin, Italy.

Rosario Vasta (R)

ALS Centre, "Rita Levi Montalcini" Department of Neuroscience, University of Turin, Turin, Italy.

Rocco Liguori (R)

Bellaria Hospital, IRCCS Istituto delle Scienze Neurologiche di Bologna, Bologna, Italy.
Department of Biomedical and NeuroMotor Sciences (DIBINEM), University of Bologna, Bologna, Italy.

Vincenzo Arena (V)

Positron Emission Tomography Centre AFFIDEA-IRMET S.p.A, Turin, Italy.

Maurizio Grassano (M)

ALS Centre, "Rita Levi Montalcini" Department of Neuroscience, University of Turin, Turin, Italy.

Francesca Palumbo (F)

ALS Centre, "Rita Levi Montalcini" Department of Neuroscience, University of Turin, Turin, Italy.

Laura Peotta (L)

ALS Centre, "Rita Levi Montalcini" Department of Neuroscience, University of Turin, Turin, Italy.

Barbara Iazzolino (B)

ALS Centre, "Rita Levi Montalcini" Department of Neuroscience, University of Turin, Turin, Italy.

Marco Pagani (M)

Institute of Cognitive Sciences and Technologies, C.N.R, Rome, Italy.
Department of Medical Radiation Physics and Nuclear Medicine, Karolinska University Hospital, Stockholm, Sweden.

Adriano Chiò (A)

ALS Centre, "Rita Levi Montalcini" Department of Neuroscience, University of Turin, Turin, Italy.
Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino, Turin, Italy.
Neuroscience Institute of Turin (NIT), Turin, Italy.
Institute of Cognitive Sciences and Technologies, C.N.R, Rome, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH